Skip to main content
Erschienen in:

10.06.2024 | Review Article

Association between choroidal thickness and diabetic macular edema: a meta-analysis

verfasst von: Zhenping Li, Fan Yang, Xiaowen Deng, Yunjiao Zhao, Haijun Gong, Qihang Zhou, Zhujue Gama, Yuqing Lan

Erschienen in: Acta Diabetologica | Ausgabe 8/2024

Einloggen, um Zugang zu erhalten

Abstract

Aims

To evaluate the association between subfoveal choroidal thickness (SFCT) and diabetic macular edema (DME).

Design

A systematic review and meta-analysis.

Methods

A retrospective or prospective study comparing SFCT in diabetic retinopathy (DR) patients with and without DME was included. The data were collected from published studies retrieved from PubMed, Web of Science, Embase, Ovid Medline, and Cochrane Library. The final search was conducted on July 2, 2023. Heterogeneity was assessed using I2 statistics, and a random-effects model was used for the meta analysis. This study calculated the weighted mean difference (WMD) and 95% confidence interval (CI) for SFCT.

Results

A total of 26 relevant studies were identified, involving a combined sample size of 3201 eyes (1302 DR-DME eyes and 1899 DR-no DME eyes). The results showed no significance between DR-DME and DR-no DME (WMD = − 3.57 μm; 95% CI −26.54 to 19.41 μm; P = 0.76). Sub-analysis based on nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) subgroups showed that the SFCT of NPDR-DME was significantly thinner than that of NPDR-no DME eyes (WMD = − 19.80 μm; 95% CI − 34.55 to − 5.04 μm; P = 0.009), while there was no significance in SFCT between PDR-DME and PDR-no DME (WMD = − 26.45 μm; 95% CI − 104.00 to 51.11 μm; P = 0.50).

Conclusion

The SFCT was thinner in NPDR-DME eyes compared to NPDR-no DME eyes. Thinning SFCT might cause retinal hypoxia, and play an important role in DME occurrence. Additionally, this study highlights the importance of considering DR grades and treatment history when evaluating SFCT between DME and no DME.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Tan GS, Cheung N, Simo R, Cheung GC, Wong TY (2017) Diabetic macular oedema. Lancet Diabetes Endocrinol 5(2):143–155PubMedCrossRef Tan GS, Cheung N, Simo R, Cheung GC, Wong TY (2017) Diabetic macular oedema. Lancet Diabetes Endocrinol 5(2):143–155PubMedCrossRef
3.
Zurück zum Zitat Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105(6):998–1003PubMedCrossRef Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105(6):998–1003PubMedCrossRef
4.
Zurück zum Zitat Zhang J, Zhang J, Zhang C et al (2022) Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications. Cells 11(21):3362PubMedPubMedCentralCrossRef Zhang J, Zhang J, Zhang C et al (2022) Diabetic macular edema: current understanding, molecular mechanisms and therapeutic implications. Cells 11(21):3362PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Ines L, Talcott KE, Santos AR et al (2018) Choroidal thickness in diabetic retinopathy assessed with swept-source optical coherence tomography. Retina J Retin Vitr Dis 38(1):173–82 Ines L, Talcott KE, Santos AR et al (2018) Choroidal thickness in diabetic retinopathy assessed with swept-source optical coherence tomography. Retina J Retin Vitr Dis 38(1):173–82
6.
Zurück zum Zitat Lee HK, Lim JW, Shin MC (2013) Comparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography. Korean J Ophthalmol 27(6):433–439PubMedPubMedCentralCrossRef Lee HK, Lim JW, Shin MC (2013) Comparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography. Korean J Ophthalmol 27(6):433–439PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Esmaeelpour M, Považay B, Hermann B et al (2011) Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci 52(8):5311–5316PubMedCrossRef Esmaeelpour M, Považay B, Hermann B et al (2011) Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci 52(8):5311–5316PubMedCrossRef
9.
Zurück zum Zitat Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH (2013) Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci 54(5):3378–3384PubMedCrossRef Kim JT, Lee DH, Joe SG, Kim JG, Yoon YH (2013) Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci 54(5):3378–3384PubMedCrossRef
11.
Zurück zum Zitat Alışık M, Işik MU (2021) The relationship between choroidal thickness and intracellular oxidised-reduced glutathione and extracellular thiol–disulfide homeostasis at different stages of diabetic retinopathy. Curr Eye Res 46(3):367–372PubMedCrossRef Alışık M, Işik MU (2021) The relationship between choroidal thickness and intracellular oxidised-reduced glutathione and extracellular thiol–disulfide homeostasis at different stages of diabetic retinopathy. Curr Eye Res 46(3):367–372PubMedCrossRef
13.
Zurück zum Zitat Wang S, Lin S, Zheng Y et al (2015) Association of choroidal thickness with diabetic retinopathy at different stages. Zhonghua Yi Xue Za Zhi 95(32):2584–2588PubMed Wang S, Lin S, Zheng Y et al (2015) Association of choroidal thickness with diabetic retinopathy at different stages. Zhonghua Yi Xue Za Zhi 95(32):2584–2588PubMed
14.
Zurück zum Zitat Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS (2012) Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 32(3):563–568PubMedPubMedCentralCrossRef Regatieri CV, Branchini L, Carmody J, Fujimoto JG, Duker JS (2012) Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina 32(3):563–568PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Andreas S (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRef Andreas S (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRef
16.
Zurück zum Zitat Adhi M, Brewer E, Waheed NK, Duker JS (2013) Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol 131(10):1267–1274PubMedPubMedCentralCrossRef Adhi M, Brewer E, Waheed NK, Duker JS (2013) Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol 131(10):1267–1274PubMedPubMedCentralCrossRef
17.
18.
Zurück zum Zitat Hajnalka H, Illes K, Laszlo SG et al (2018) Choroidal thickness changes in non-treated eyes of patients with diabetes: swept-source optical coherence tomography study. Acta Diabetol 55(9):927–34CrossRef Hajnalka H, Illes K, Laszlo SG et al (2018) Choroidal thickness changes in non-treated eyes of patients with diabetes: swept-source optical coherence tomography study. Acta Diabetol 55(9):927–34CrossRef
19.
Zurück zum Zitat Kim M, Ha MJ, Choi SY, Park YH (2018) Choroidal vascularity index in type-2 diabetes analyzed by swept-source optical coherence tomography. Sci Rep 8(1):70PubMedPubMedCentralCrossRef Kim M, Ha MJ, Choi SY, Park YH (2018) Choroidal vascularity index in type-2 diabetes analyzed by swept-source optical coherence tomography. Sci Rep 8(1):70PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Hyen LS, Jaeyoung K, Hyewon C, Chan KH (2014) Changes of choroidal thickness after treatment for diabetic retinopathy. Curr Eye Res 39(7):736–44CrossRef Hyen LS, Jaeyoung K, Hyewon C, Chan KH (2014) Changes of choroidal thickness after treatment for diabetic retinopathy. Curr Eye Res 39(7):736–44CrossRef
21.
Zurück zum Zitat Nakano H, Hasebe H, Murakami K, Nakamura Y, Fukuchi T (2022) Choroidal vascular density in diabetic retinopathy assessed with swept-source optical coherence tomography. Retina 43(1):34–41CrossRef Nakano H, Hasebe H, Murakami K, Nakamura Y, Fukuchi T (2022) Choroidal vascular density in diabetic retinopathy assessed with swept-source optical coherence tomography. Retina 43(1):34–41CrossRef
22.
Zurück zum Zitat Querques G, Lattanzio R, Querques L et al (2012) Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 53(10):6017–6024PubMedCrossRef Querques G, Lattanzio R, Querques L et al (2012) Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 53(10):6017–6024PubMedCrossRef
23.
Zurück zum Zitat Rewbury R, Want A, Varughese R, Chong V (2016) Subfoveal choroidal thickness in patients with diabetic retinopathy and diabetic macular oedema. Eye (London) 30(12):1568–1572CrossRef Rewbury R, Want A, Varughese R, Chong V (2016) Subfoveal choroidal thickness in patients with diabetic retinopathy and diabetic macular oedema. Eye (London) 30(12):1568–1572CrossRef
24.
Zurück zum Zitat Sahinoglu-Keskek N, Altan-Yaycioglu R, Canan H, Coban-Karatas M (2018) Influence of glycosylated hemoglobin on the choroidal thickness. Int Ophthalmol 38(5):1863–1869PubMedCrossRef Sahinoglu-Keskek N, Altan-Yaycioglu R, Canan H, Coban-Karatas M (2018) Influence of glycosylated hemoglobin on the choroidal thickness. Int Ophthalmol 38(5):1863–1869PubMedCrossRef
25.
Zurück zum Zitat Sheth JU, Giridhar A, Rajesh B, Gopalakrishnan M (2017) Characterization of macular choroidal thickness in ischemic and nonischemic diabetic maculopathy. Retina 37(3):522–528PubMedCrossRef Sheth JU, Giridhar A, Rajesh B, Gopalakrishnan M (2017) Characterization of macular choroidal thickness in ischemic and nonischemic diabetic maculopathy. Retina 37(3):522–528PubMedCrossRef
26.
Zurück zum Zitat Sidorczuk P, Obuchowska I, Konopinska J, Dmuchowska DA (2022) Correlation between choroidal vascularity index and outer retina in patients with diabetic retinopathy. J Clin Med 11(13):3882PubMedPubMedCentralCrossRef Sidorczuk P, Obuchowska I, Konopinska J, Dmuchowska DA (2022) Correlation between choroidal vascularity index and outer retina in patients with diabetic retinopathy. J Clin Med 11(13):3882PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Ünsal E, Eltutar K, Zirtiloǧlu S, Dinçer N, ErkulÖ S, Güngel H (2014) Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8:637–642PubMedPubMedCentralCrossRef Ünsal E, Eltutar K, Zirtiloǧlu S, Dinçer N, ErkulÖ S, Güngel H (2014) Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8:637–642PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Verma A, Nagpal M, Mehrotra N (2016) In vivo assessment of choroid in diabetic retinopathy by enhanced depth imaging in spectral domain optical coherence tomography. Asia-Pac J Ophthalmol (PA) 5(5):319–323CrossRef Verma A, Nagpal M, Mehrotra N (2016) In vivo assessment of choroid in diabetic retinopathy by enhanced depth imaging in spectral domain optical coherence tomography. Asia-Pac J Ophthalmol (PA) 5(5):319–323CrossRef
29.
Zurück zum Zitat Wang X, Li S, Li W, Hua Y, Wu Q (2018) Choroidal variations in diabetic macular edema: fluorescein angiography and optical coherence tomography. Curr Eye Res 43(1):102–108PubMedCrossRef Wang X, Li S, Li W, Hua Y, Wu Q (2018) Choroidal variations in diabetic macular edema: fluorescein angiography and optical coherence tomography. Curr Eye Res 43(1):102–108PubMedCrossRef
30.
Zurück zum Zitat Zhang Z, Meng X, Wu Z et al (2015) Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 12-week longitudinal study. Invest Ophthalmol Vis Sci 56(4):2631–2638PubMedCrossRef Zhang Z, Meng X, Wu Z et al (2015) Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 12-week longitudinal study. Invest Ophthalmol Vis Sci 56(4):2631–2638PubMedCrossRef
31.
Zurück zum Zitat Choi SU, Kim YJ, Lee JY, Lee J, Yoon YH (2023) Qualitative and quantitative evaluation of diabetic choroidopathy using ultra-widefield indocyanine green angiography. Sci Rep 13(1):2577PubMedPubMedCentralCrossRef Choi SU, Kim YJ, Lee JY, Lee J, Yoon YH (2023) Qualitative and quantitative evaluation of diabetic choroidopathy using ultra-widefield indocyanine green angiography. Sci Rep 13(1):2577PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Lutty GA, Cao J, McLeod DS (1997) Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 151(3):707–714PubMedPubMedCentral Lutty GA, Cao J, McLeod DS (1997) Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 151(3):707–714PubMedPubMedCentral
34.
Zurück zum Zitat Hidayat AA, Fine BS (1985) Diabetic choroidopathy, Light and electron microscopic observations of seven cases. Ophthalmology 92(4):512–22PubMedCrossRef Hidayat AA, Fine BS (1985) Diabetic choroidopathy, Light and electron microscopic observations of seven cases. Ophthalmology 92(4):512–22PubMedCrossRef
35.
Zurück zum Zitat Bartsch DU, Weinreb RN, Zinser G, Freeman WR (1995) Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol 120(5):642–651PubMedCrossRef Bartsch DU, Weinreb RN, Zinser G, Freeman WR (1995) Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol 120(5):642–651PubMedCrossRef
36.
Zurück zum Zitat Nagaoka T, Kitaya N, Sugawara R et al (2004) Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 88(8):1060–1063PubMedPubMedCentralCrossRef Nagaoka T, Kitaya N, Sugawara R et al (2004) Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol 88(8):1060–1063PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Li Z, Alzogool M, Xiao J, Zhang S, Zeng P, Lan Y (2018) Optical coherence tomography angiography findings of neurovascular changes in type 2 diabetes mellitus patients without clinical diabetic retinopathy. Acta Diabetol 55(10):1075–1082PubMedCrossRef Li Z, Alzogool M, Xiao J, Zhang S, Zeng P, Lan Y (2018) Optical coherence tomography angiography findings of neurovascular changes in type 2 diabetes mellitus patients without clinical diabetic retinopathy. Acta Diabetol 55(10):1075–1082PubMedCrossRef
38.
Zurück zum Zitat Andreas R, Andreas B (2013) New functions of Müller cells. Glia 61(5):651–678CrossRef Andreas R, Andreas B (2013) New functions of Müller cells. Glia 61(5):651–678CrossRef
39.
Zurück zum Zitat Caplan MJ (1997) Membrane polarity in epithelial cells: protein sorting and establishment of polarized domains. Am J Physiol 272(4 Pt 2):F425–F429PubMed Caplan MJ (1997) Membrane polarity in epithelial cells: protein sorting and establishment of polarized domains. Am J Physiol 272(4 Pt 2):F425–F429PubMed
40.
Zurück zum Zitat Kohno T, Ishibashi T, Inomata H, Ikui H, Taniguchi Y (1983) Experimental macular edema of commotio retinae: preliminary report. Jpn J Ophthalmol 27(1):149–156PubMed Kohno T, Ishibashi T, Inomata H, Ikui H, Taniguchi Y (1983) Experimental macular edema of commotio retinae: preliminary report. Jpn J Ophthalmol 27(1):149–156PubMed
42.
Zurück zum Zitat Andreas B, Thomas P, Jens G et al (2006) Müller cells in the healthy and diseased retina. Prog Retin Eye Res 25(4):397–424CrossRef Andreas B, Thomas P, Jens G et al (2006) Müller cells in the healthy and diseased retina. Prog Retin Eye Res 25(4):397–424CrossRef
43.
Zurück zum Zitat Spaide RF (2016) Retinal vascular cystoid macular edema: review and new theory. Retina (PA) 36(10):1823–1842CrossRef Spaide RF (2016) Retinal vascular cystoid macular edema: review and new theory. Retina (PA) 36(10):1823–1842CrossRef
44.
Zurück zum Zitat Alejandra D, Alexandre M, Alexandre M et al (2018) Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res 63:20–68CrossRef Alejandra D, Alexandre M, Alexandre M et al (2018) Mechanisms of macular edema: beyond the surface. Prog Retin Eye Res 63:20–68CrossRef
45.
Zurück zum Zitat Andreas R, Antje W, Thomas P, Ianors I, Peter W, Andreas B (2007) Müller cells as players in retinal degeneration and edema. Graefe’s Arch Clin Exp Ophthalmol 245(5):627–36CrossRef Andreas R, Antje W, Thomas P, Ianors I, Peter W, Andreas B (2007) Müller cells as players in retinal degeneration and edema. Graefe’s Arch Clin Exp Ophthalmol 245(5):627–36CrossRef
46.
Zurück zum Zitat Paulo K, Bernd B, Venkatraman S et al (2002) Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering. Glia 39(3):292–303CrossRef Paulo K, Bernd B, Venkatraman S et al (2002) Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering. Glia 39(3):292–303CrossRef
47.
Zurück zum Zitat Tianqin W, Chaoyang Z, Hai X et al (2021) Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy. Eye Vis (Lond) 8(1):13CrossRef Tianqin W, Chaoyang Z, Hai X et al (2021) Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy. Eye Vis (Lond) 8(1):13CrossRef
48.
Zurück zum Zitat Kase S, Endo H, Takahashi M et al (2020) Alteration of choroidal vascular structure in diabetic retinopathy. Br J Ophthalmol 104(3):417–421PubMedCrossRef Kase S, Endo H, Takahashi M et al (2020) Alteration of choroidal vascular structure in diabetic retinopathy. Br J Ophthalmol 104(3):417–421PubMedCrossRef
49.
Zurück zum Zitat Zhengwei Z, Meng Xiaomei W et al (2015) Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 12-week longitudinal study. Invest Ophthalmol Vis Sci 56(4):2631–2638CrossRef Zhengwei Z, Meng Xiaomei W et al (2015) Changes in choroidal thickness after panretinal photocoagulation for diabetic retinopathy: a 12-week longitudinal study. Invest Ophthalmol Vis Sci 56(4):2631–2638CrossRef
50.
Zurück zum Zitat Ibrahim T, Eyyup K, Ozgur ZM, Eray A, Nihat (2015) Choroidal thickness in relation to sex age refractive error and axial length in healthy Turkish subjects. Int Ophthalmol 35(3):403–410CrossRef Ibrahim T, Eyyup K, Ozgur ZM, Eray A, Nihat (2015) Choroidal thickness in relation to sex age refractive error and axial length in healthy Turkish subjects. Int Ophthalmol 35(3):403–410CrossRef
51.
Zurück zum Zitat Waldstein SM, Faatz H, Szimacsek M et al (2015) Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography. J Eye (Lond) 29(3):409–415CrossRef Waldstein SM, Faatz H, Szimacsek M et al (2015) Comparison of penetration depth in choroidal imaging using swept source vs spectral domain optical coherence tomography. J Eye (Lond) 29(3):409–415CrossRef
Metadaten
Titel
Association between choroidal thickness and diabetic macular edema: a meta-analysis
verfasst von
Zhenping Li
Fan Yang
Xiaowen Deng
Yunjiao Zhao
Haijun Gong
Qihang Zhou
Zhujue Gama
Yuqing Lan
Publikationsdatum
10.06.2024
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 8/2024
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-024-02306-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

  • 10.01.2025
  • COPD
  • Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

Kaffeegenuss sicher bei Vorhofflimmern

Menschen mit Vorhofflimmern fürchten oft, Kaffee könnte schlecht für ihr Herz sein. Solche Ängste sind offenbar unbegründet: Zwei Schweizer Untersuchungen deuten sogar auf eine reduzierte Rate von kardiovaskulären Ereignissen unter Kaffeetrinkern.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.